title: Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls.
authors: Atmaram
authors: A
authors: Yarlagadda
authors: Badalin
authors: B
authors: Helvink
authors: Caroline
authors: C
authors: Chou
authors: Kenneth
authors: K
authors: Gladieux
authors: Adrienne
authors: A
authors: Keller
authors: Anita
authors: A
authors: Clayton
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000032:analysis*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D019208:Brain-Derived Neurotrophic Factor / Q000276:immunology; D035061:Control Groups; D004409:Dyskinesia, Drug-Induced / Q000201:enzymology / Q000276:immunology*; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy / Q000201:enzymology* / Q000276:immunology
chemical_list: D000906:Antibodies; D014150:Antipsychotic Agents; D019208:Brain-Derived Neurotrophic Factor; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1; C401141:glutamate decarboxylase 2